TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
Report Overview The report provides comprehensive information on the therapeutics under development for Acute Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Pain and features dormant and discontinued projects. Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Read More At: http://www.researchbeam.com/acute-pain-pipeline-review-h1-2016-market
Report Overview Scope • The report provides a snapshot of the global therapeutic landscape of Acute Pain • The report reviews pipeline therapeutics for Acute Pain by companies and universities/research institutes based on information derived from company and industryspecific sources • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
Reasons to buy • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Identify potential new clients or partners in the target demographic • Develop strategic initiatives by understanding the focus areas of leading companies Read More At: http://www.researchbeam.com/acute-pain-pipeline-review-h1-2016-market
Table of Content List Of Figures List of Figures Number of Products under Development for Acute Pain, H1 2016 15 Number of Products under Development for Acute Pain - Comparative Analysis, H1 2016 16 Number of Products under Development by Companies, H1 2016 17 Comparative Analysis by Late Stage Development, H1 2016 22 Comparative Analysis by Clinical Stage Development, H1 2016 23 Comparative Analysis by Early Stage Products, H1 2016 24 Assessment by Monotherapy Products, H1 2016 70 Assessment by Combination Products, H1 2016 71 Number of Products by Top 10 Targets, H1 2016 72 Number of Products by Stage and Top 10 Targets, H1 2016 72 Number of Products by Top 10 Mechanism of Actions, H1 2016 75 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 75 Number of Products by Top 10 Routes of Administration, H1 2016 78 Number of Products by Stage and Top 10 Routes of Administration, H1 2016 78 Number of Products by Molecule Types, H1 2016 80 Number of Products by Stage and Molecule Types, H1 2016 80
Enquire At : http://www.researchbeam.com/acute-pain-pipeline-review-h1-2016-market/enquireabout-report
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/acute-pain-pipeline-review-h1-2016market/enquire-about-report
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States